Inicio Publicaciones científicas Unidad de Investigación
Publicaciones científicas Unidad de Investigación
McNicholl AG, Marin AC, Molina-Infante J, Castro M, Barrio J, Ducons J, Calvet X, de la Coba C, Montoro M, Bory F, Perez-Aisa A, Forné M, Gisbert JP; On behalf of the participant centres.Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice . Gut. 2013 May 11. [Epub ahead of print]
Bernaudo D, Coll R, Sánchez Muñoz-Torrero JF, Pascual MT, García-Díaz AM, Alvarez LR, Monreal M; FRENA Investigators. Renal function and short-term outcome in stable outpatients with coronary, cerebrovascular or peripheral artery disease . Atherosclerosis. 2013 Jul;229(1):258-62
Review article: proton pump inhibitor therapy for suspected eosinophilicoesophagitis . AlimentPharmacolTher. 2013 Jun;37(12):1157-64Cabrera C. M. , J. M. Urra, A. Carreño A, and J. Zamorano Differential expression of CD30 on CD3 T-lymphocytes in patients with systemic lupus erythematosus. Scand J Immunol. 2013 Jun 24.doi: 10.1111/sji.12088. [Epub ahead of print]. PMID 23790231
[III Spanish Consensus Conference on Helicobacter pylori infection] . GastroenterolHepatol. 2013 May;36(5):340-74 Masa J. F., J.Corral, J. Gomez de Terreros, J. Duran-Cantolla, M. Cabello, L. Hernández-Blasco, C. Monasterio, A. Alonso, E. Chiner, F. Aizpuru, J. Zamorano, R. Cano, J.M. Montserrat; Collaboratinggroup, Garcia-Ledesma E, Pereira R, Cancelo L, Martinez A, Sacristan L, Salord N, Carrera M, Sancho-Chust JN, Embid C. Significance of including a surrogate arousal for sleep apnea-hypopnea syndrome diagnosis by respiratory polygraphy. Sleep. 2013 Feb 1;36(2):249-57. doi: 10.5665/sleep.2384. PMID: 23372273
Aguilar E, García-Díaz AM, Sánchez Muñoz-Torrero JF, Alvarez LR, Piedecausa M, Arnedo G, Monreal M; FRENA Investigators. 2012. Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation . Thromb Res. 2012 Sep;130(3):390-5
Gisbert JP, Molina-Infante J, Marin AC, Vinagre G, Barrio J, McNicholl AG. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection . Scand J Gastroenterol. 2013 Jun;48(6):652-6.
Molina-Infante J, Romano M, Fernandez-Bermejo M, Federico A, Gravina AG, Pozzati L, Garcia-Abadia E, Vinagre-Rodriguez G, Martinez-Alcala C, Hernandez-Alonso M, Miranda A, Iovene MR, Pazos-Pacheco C, Gisbert JP. Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance . Gastroenterology. 2013 Jul;145(1):121-128.
Sanchez Muñoz-Torrero, J.F., M.D. Rivas, R. Alonso, L. Crespo, A. Costo, M. Roman, C. Martin, and J. Zamorano. Influence of lipoprotein (a) on inflammatory biomarkers in metabolic syndrome . South Med. J. 2012; 105:339-343
Molina-Infante, J, and J. ZamoranoDistinguishing eosinophilic esophagitis from gastroesophageal reflux disease upon PPI refractoriness: What about PPI-responsive esophageal eosinophilia ?. Digestion 2012; 85:210
Molina-Infante J, Pazos-Pacheco C, Vinagre-Rodriguez G, Perez-Gallardo B, Dueñas-Sadornil C, Hernandez-Alonso M, Gonzalez-Garcia G, Mateos-Rodriguez JM, Fernandez-Bermejo M, Gisbert JP. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains . Helicobacter. 2012 Aug;17(4):269-76
Molina-Infante J, Dueñas-Sadornil C, Mateos-Rodriguez JM, Perez-Gallardo B, Vinagre-Rodríguez G, Hernandez-Alonso M, Fernandez-Bermejo M, Gonzalez-Huix F Nonanesthesiologist-administered propofol versus midazolam and propofol, titrated to moderate sedation, for colonoscopy: a randomized controlled trial . DigDisSci. 2012 Sep;57(9):2385-93.
Sanchez Muñoz-Torrero, J.F., D. Escudero, C. Suarez, C. Sanclemente, M.T. Pascual, J. Zamorano, M. Monreal and the FRENA Investigators. Concomitant use of proton-pump inhibitors and clopidogrel in patients with coronary, cerebrovascular or peripheral artery disease.Findings from the FRENA Registry. J Cardiovasc Pharm 2011; 57:13-19
Telmisartan improves insulin resistance in patients with low cytokine levels. J. Invest. Med. 2011; 59:602-605. Vega J., S. Romani, F.J. Garciperez, L. vicente, N. Pacheco, J. Zamorano, J.J. Gomez-Barrado, and J.F. Sanchez. Peripheral arterial disease: Efficacy of the oscillometric method . Rev EspCardiol. 2011; 64:619-621.
Masa JF, Corral J, Pereira R, Duran-Cantolla J, Cabello M, Hernández-Blasco L, Monasterio C, Alonso A, Chiner E, Zamorano J, Aizpuru F, Montserrat JM; SpanishSleep Network. Therapeutic decision-making for sleep apnea and hypopnea syndrome using home respiratory polygraphy: a large multicentric study . Am J RespCrit Care Med. 2011; 184(8):964-71.
Muñoz-Torrero JF, Zamorano J. Vertebral fractures . N Engl J Med. 2011; 365(7):673-4
Molina-Infante J, Ferrando-Lamana L, Ripoll C, Hernandez-Alonso M, Mateos JM, Fernandez-Bermejo M, Dueñas C, Fernandez-Gonzalez N, Quintana EM, Gonzalez-Nuñez MA. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. ClinGastroenterolHepatol. 2011 Feb;9(2):110-7
Molina-Infante, J, J. Zamorano, M.D. Rivas, and M. Fernandez-Bermejo. Proton pump inhibitors therapy for eosinophilic esophagitis . J AllerTher 2011; S8(002):1-4.
Muñoz-Torrero JF, Bounameaux H, Pedrajas JM, Lorenzo A, Rubio S, Kearon C, Hernández L, Monreal M; Registro Informatizado de la Enfermedad TromboEmbólica (RIETE) Investigators. Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis . J Vasc Surg. 2011 Dec;54(6 Suppl):26S-32S
Garcia-Diaz AM, Marchena PJ, Toril J, Arnedo G, Muñoz-Torrero JF, Yeste M, Aguilar E, Monreal M; FRENA Investigators. Alcohol consumption and outcome in stable outpatients with peripheral artery disease . J Vasc Surg. 2011 Oct;54(4):1081-7
Camafort M, Alvarez-Rodríguez LR, Muñoz-Torrero JF, Sahuquillo JC, López-Jiménez L, Coll R, Monreal M; FRENA Investigators. Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease.Findingsfromthe FRENA Registry . Diabet Med. 2011 Jan;28(1):73-80.
Molina-Infante, J., and J. Zamorano Acid-Suppressive Therapy and Eosinophilic Esophagitis: Friends or Foes ? Am J Gastroenterol 2010; 105:699-700.
Molina-Infante J, Perez-Gallardo B, Fernandez-Bermejo M, Hernandez-Alonso M, Vinagre G, Dueñas C, Mateos-Rodriguez JM, Gonzalez-Garcia G, Abadia EG, Gisbert JP. Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication . Aliment PharmacolTher. 2010 May;31(10):1077-84
Vega, J., S. Romani, F.J. Garciperez, J. Zamorano, and J.F. Sanchez. 2010. Ankle-brachial index measurement in primary care setting . South Med. J. 2010; 103:590. IF 0.76 Q3
J.F. Sanchez, P. Barquilla, R. Velasco, C. Fernandez, N. Pacheco, L. Vicente, J.L. Chicon, S. Trejo. J. Zamorano, and A. Lorenzo. Adverse drug reactions in internal medicine units, and risk factors associated. Eur. J. Clin. Pharmacol.2010; 66:1257-1264.
Sanchez Muñoz-torrero, J.F., L. Crespo, J.M. Ramirez, F. alvarez, J. Luengo, J. Mateos, N.R. Robles, J. Zamorano, and A. Costo. Efectos de un consejo nutricional simple en pacientes de alto riesgo vascular . Clin Invest Arterioscl. 2011; 23(1):8-14.
Masa, J.F., M.T. Gonzalez, R. Pereira, M. Mota, J.A. Riesco, J. Corral, J. Zamorano, M. Rubio, J. Teran, and R. Farre. Validity of spirometry performed on-line Eur. Respir. J. 2011; 37:911-918.
Masa J.F., J. Corral., J. Teran,.M.J. Martin, C. Disdier, M. Rubio, M. Mota, J. Zamorano, and J.M. Montserrat. Apnoeic and obstructive non-apnoeic sleep respiratory events. Eur Respir J. 2009; 34:156-161
Cortes, J.R., M.D. Rivas, J. Molina-Infante, M.A. Gonzalez-Nuñez, M. Perez-G, J.F. Masa, J.F. Sanchez, and J. Zamorano. Omeprazole inhibits IL-4 and IL-13 signaling STAT6 activation and reduces lung inflammation in murine asthma. J AllergyClinImmunol. 2009; 124:607-610, 610e1
Barba R, Bisbe J, Pedrajas JN, Toril J, Monte R, Muñoz-Torrero JF, Monreal M; FRENA Investigators. Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry . Eur J CardiovascPrevRehabil. 2009 Aug;16(4):457-63.
Roldan V, Lecumberri R, Muñoz-Torrero JF, Vicente V, Rocha E, Brenner B, Monreal M; RIETE Investigators. Thrombophilia testing in patients with venous thromboembolism.Findings from the RIETE registry . Thromb Res. 2009 Jun;124(2):174-7.
Perez-G, M., J.R. Cortes, M.D. Rivas, F. Masa, and J. Zamorano Treatment of cells with n-alpha-tosyl-L-phenylalanine-chloromethyl ketone induces the proteolytic loss of STAT6 transcription factor . Mol Immunol. 2008; 45:3896-3901.
Molina-Infante J, Ferrando-Lamana L, Mateos-Rodríguez JM, Pérez-Gallardo B, Prieto-Bermejo AB. Overlap of reflux and eosinophilic esophagitis in two patients requiring different therapies: a review of the literature. World J Gastroenterol. 2008 Mar 7;14(9):1463-6
Sanchez de Cos, J., D. Masjoans, M.A. Sojo, J. Zamorano, C. Disdier, and M. C. Perez. 2007. Metástasis encefálicas silentes en la estadificación inicial del cáncer de pulmón. Evaluación mediante tomografía computarizada y resonancia magnética. ArchBronconeumol. 2007; 43:386-391.
Cortes J.R., M. Perez-G, M.D. Rivas, and J. Zamorano. Kaempferol inhibits IL-4-induced STAT6 activation by specifically targeting JAK3. J Immunol. 2007; 179:3881-3887.
Monreal M, Muñoz-Torrero JF, Naraine VS, Jiménez D, Soler S, Rabuñal R, Gallego P; RIETE Investigators. Pulmonary embolism in patients with chronic obstructive pulmonary disease or congestive heart failure. Am J Med. 2006 Oct;119(10):851-8
Zamorano J., M.D. Rivas, F. Setien, and M. Perez-G. Proteolytic regulation of activated STAT6 by calpains. J. Immunol. 2005; 174:2843-2848.
Zamorano, J., M.D. Rivas, A. Garcia-Trinidad, C.K. Qu, and A.D. Keegan. Phosphatidylcholine-specific phospholipase C activity is necessary for the activation of STAT6. J. Immunol . 2003; 171:4203-4209
J. Zamorano, M.D. Rivas, and M. Perez-G. Interleukin-4: A multifunctionalcytokine . Inmunología 2003; 22:215-224.
Perez-G M., M. Melo, A.D. Keegan, and J. Zamorano. Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6. J. Immunol. 2002; 168:1428-1434.
